References
- Gaynor E.R., Fisher R. Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphoma. Sem. Oncol. 1991; 5: 12–17, supp. 7
- Horning S.J., Rosenberg S. The natural history of initially untreated low grade non-Hodgkin's lymphoma. N. Engl, J. Med. 1984; 311: 1471–1475
- Magrath I.T. The non-Hodgkin's lymphomas. Edward Arnold, London 1983
- Kartner N., Riordan J.R., Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983; 221: 1285–1288
- Croop J.M., Gros P., Houseman D.E. Genetics of multidrug resistence. J. Clin. Invest. 1988; 81: 1303–1309
- Endicott J.A., Ling V. The biochemistry of P-glyco-protein-mediated multidrug resistance. Ann. Rev. Biochem. 1989; 58: 137–171
- Van der Blick A.M., Borst P. Multidrug resistance. Adv. Cancer Res. 1989; 52: 165–203
- Kartner N., Evemden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1983; 316: 820–823
- Roninson I.B., Chin J.E., Choi K., Gros P., Housman D.E., Fojo A., Shen D.W., Gottesman M., Pastan I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 4538–4542
- Dalton W.S., Grogan T.M., Meltzer P.S., Scheper R.J., Durie B.G.M., Taylor C.W., Miller T.P., Salmon S.E. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma. Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J. Clin. Oncol. 1989; 7: 415–424
- Salmon S.E., Grogan T.M., Miller T., Scheper R., Dalton W.S. Prediction of doxorubicin resistance in vitro in myteloma, lymphoma and breast cancer by P-glycoprotein staining. J. Natl. Cancer. Inst., 81: 696–699
- Brophy N.A., Marie J.P., Rojas V.A., Warnke R.A., McFall P.J., Smith S.D., Sikic B.I. Mdr-1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Leukemia 1994; 8: 327–335
- Stansfeld A.G., Diebold J., Kapanci Y., Kelenyi G., Lennert K., Mioduszewska O., Noel H. Updated Kiel classification for lymphomas. Lancet 1988; i: 292–293
- Chomczynski P., Sacchi G. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem. 1987; 162: 156–159
- Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning—A Laboratory Manual2nd edn. CSH Laboratory Press, Cold Spring Harbor 1989
- Finnegan M.C.M., Goepel J.R., Hancock B.W., Goyns M.H. Investigation of the expression of housekeeping genes in non-Hodgkin's lymphoma. Leukemia Lymphoma 1993; 10: 387–393
- Finnegan M.C.M., Goepel J.R., Royds J., Hancock B.W., Goyns M.H. Elevated levels of MDM-2 and P53 expression are associated with high grade non-Hodgkin's lymphomas. Cancer Lett. 1994, In press
- Cordon-Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 1990; 38: 1277–1287
- Chaudhary P.M., Roninson I.B. Expression and activity of P-glycoprotein a multidrug efflux pump in human hematopoietic stem cells. Cell 1991; 66: 85–94
- Neyfakh A.A., Serpinskaya A.S., Chervousky A.V., Apasov S.G., Kazarov A.R. Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp. Cell Res. 1989; 185: 496–505
- Kaye S.B. P glycoprotein (P-gp) and drug resistance—time for reappraisal?. Oncogene 1993; 67: 641–643